circulating IGF-I (25) . The majority of IGF-I in circulation is bound to the IGF binding proteins (IGFBP), a family of structurally homologous proteins that influence the half-life and bioavailability of IGF-I to the tissues (1) . Most (Ͼ80%) IGF-I in plasma is bound to IGFBP-3 and an acid-labile subunit, forming a large 150-kDa ternary complex that is unable to cross the endothelial barrier. The remainder of IGF-I in plasma is bound to one of the lower molecular mass IGFBP, whereas only a very small amount (Ͻ1%) circulates in the free form (1) .
Of all the currently identified IGF binding proteins, IGFBP-1 is the only one to show rapid and marked fluctuation in human plasma (16, 17) . The major physiological regulator of tissue IGFBP-1 expression is insulin (16, 17) . However, the IGFBP-1 promoter contains a glucocorticoid response element, a hepatic nuclear factor-1 element, and a cAMP response element in addition to an insulin regulatory sequence (17) . Hence, the potential for regulation of this rapidly metabolized protein by other factors exists.
Several reports note that prolonged endurance exercise induces very high circulating concentrations of IGFBP-1 in humans and rats (12, 15, 21, 27) . The mechanism for such high circulating concentrations and their physiological significance are unclear. Infusion of IGFBP-1 neutralizes insulin-like activity of IGF-I and raises fasting blood glucose concentrations in vivo (18). Therefore, it is proposed that IGFBP-1 may have an important role in glucoregulation during and after exercise (12, 15) . However, consumption of a purely carbohydrate drink during cycling exercise to maintain plasma glucose and insulin levels does not prevent plasma IGFBP-1 levels from rising in humans (12) . Hence, factors other than glucose and insulin appear to induce IGFBP-1 production during and after exercise.
It has been reported that feeding rats a low-protein diet induces hepatic and kidney IGFBP-1 mRNA expression (28) and that withdrawal of amino acids from culture media results in increased expression of IGFBP-1 mRNA in HepG2 cells and isolated hepatocytes (14) . These data suggest that amino acid availability may influence IGFBP-1 gene expression. Therefore, we were interested in exploring the effects of feeding a protein-containing meal on IGFBP-1 production after prolonged exercise. The objectives of this investigation were threefold: 1) to characterize the plasma and hepatic IGFBP-1 profile during a 12-h recovery period after treadmill exercise, 2) to define the changes in IGFBP-1 in relation to plasma glucose, insulin, and IGF-I, and 3) to determine the impact of postexercise meal feeding on the IGFBP-1 response. This study demonstrates that the IGFBP-1 response to exercise is short in duration and is not related to nutrient consumption after exercise. (3-[ 125 I]iodotyrosyl)insulin-like growth factor I and [ 32 P]dCTP were purchased from Amersham (Arlington Heights, IL).
EXPERIMENTAL PROCEDURES

Materials
Animals and Experimental Design
The animal facilities and protocol were reviewed and approved by the Institutional Animal Care Review Board of the University of Illinois. In both experiments, male SpragueDawley rats (Harlan Sprague Dawley, Indianapolis, IN), initially weighing 140-150 g, were individually housed in wire-bottom cages in a room maintained at 23-25°C with a 12:12-h light-dark cycle. All animals were freely provided tap water and a commercial diet (Harlan-Teklad Rodent Chow, Madison, WI) until the experimental run. The day after arrival, all animals began an 8-day treadmill acclimation schedule that gradually increased in either speed or duration up to 26 m/min for 15 min. Animals that refused to run during the acclimation period were eliminated from the study. All exercise sessions commenced at the beginning of the light cycle after recording of body weight and were performed on a motor-driven treadmill. The experimental run consisted of 2 h of treadmill running at 26 m/min (1.5% grade). Previous reports on energy expenditure in this strain of rat indicate the intensity of the experimental run to be ϳ75% maximal oxygen consumption (24) . In both experiments, food was removed from all animals 4 h before the experimental run. Experiment 1. On the day of the experiment, rats were randomly assigned to one of two treatment groups: C, nonexercised control rats, or E, exercised rats. Animals were allowed free access to water after the treadmill bout, but no food was available throughout the 12-h recovery period. Four rats per treatment group were killed at 15 min and 1, 4, 8, and 12 h postexercise.
Experiment 2. On the day of the experiment, animals were randomly assigned to one of three treatment groups: C, nonexercised control rats; E, exercised and food deprived after the experimental run; M, exercised and administered a nutritionally complete meal immediately after exercise. The nutritionally complete meal was prepared and administered exactly as previously described (10) . The caloric density was 8.8 kJ/ml (54.5% energy from carbohydrate, 31.5% energy from fat, and 14% energy from protein). The experimental dose was administered by gavage immediately after the experimental run and provided ϳ15% of daily energy intake for this age and strain of rat (10) . All animals were allowed free access to water after the treadmill bout, but no food was available after exercise beyond the defined postexercise meal. Four rats per treatment group were killed at 15 min and four at 1 h, four at 3 h, and four at 12 h postexercise.
Biological Samples
At each designated time point, animals were anesthetized by carbon dioxide overdose and killed by decapitation. Trunk blood was collected in heparinized tubes and centrifuged at 1,800 g for 10 min to obtain plasma. The liver was quickly excised, rinsed in ice-cold saline, blotted, and frozen in liquid nitrogen before storage at Ϫ80°C.
Plasma Measurements
Plasma glucose was analyzed by a glucose oxidase automated method (YSI model 2300 analyzer, Yellow Springs Instruments, Yellow Springs, OH). Plasma insulin was analyzed by radioimmunoassay (Linco Research, St. Louis, MO). Plasma IGF-I was measured by a specific RIA following acid chromatography to remove IGFBP, as previously described (29) . All samples were analyzed within a single assay with an intra-assay coefficient of variation of 6%. Plasma IGFBP profiles were characterized by SDS-PAGE and Western ligand blotting, as previously described (29) . Plasma samples (3 l) were separated on a 12% SDS-polyacrylamide gel, the proteins were transferred to a nitrocellulose membrane, and the membrane was incubated overnight with 125 I-labeled IGF-I. IGFBP were visualized by autoradiography for 7 days at Ϫ80°C. Plasma IGFBP-1 was measured by a specific RIA, as previously described (19) , with an intra-assay coefficient of variation of 5.4%.
RNA Preparation and Tissue mRNA Analysis
Frozen hepatic tissue was powdered under liquid nitrogen with a mortar and pestle. Total cellular RNA was isolated from 100-mg samples of liver by the TRI-Reagent method (7), and the quantity and purity of the RNA were determined by the absorbance ratio at optical densities of 260 and 280 nm. Hepatic IGFBP-1 and -2 mRNA expression was determined by Northern analysis. For Northern blot, 20-g samples were size-fractionated on a 1.2% agarose-formaldehyde gel and capillary transferred to a 0.45-m nitrocellulose membrane in 10ϫ SSC (1.5 mol/l NaCl and 0.15 mol/l trisodium citrate). The membrane was baked for 1 h at 80°C before hybridization. Also before hybridization, membranes were incubated in 225-mm bottles in a hybridization oven (Bellco, Vineland, NJ) for 2 h at 65°C in a buffer solution containing 10 g/l BSA, 70 g/l SDS, 0.45 mol/l NaHP 4 (pH 7.2), 0.25 mol/l NaCl, and 0.001 mol/l EDTA. Hybridizations were performed in this same buffer at 65°C for 12-24 h, and membranes were probed with random-prime [
32 P]dCTP-labeled rat cDNAs for IGFBP-1 (20) and IGFBP-2 (4). Membranes were also probed with a cDNA for chicken ␤-actin (generously provided by Dr. Lawrence Schook, University of Minnesota) to correct for loading variation. After hybridization, membranes were rinsed three times with 1 g/l SDS in 0.2ϫ SSC buffer (0.03 mol/l NaCl and 0.003 mol/l trisodium citrate) for 10 min at 65°C. Membranes were wrapped in plastic wrap and visualized by autoradiography at Ϫ80°C for 2-3 days.
Densitometry
Audioradiographs of Western ligand and Northern blots were quantitated using relative pixel intensities determined by a FotoAnalyst II Imager System and Collage software (Fotodyne, New Berlin, WI). For Northern blots, densities of IGFBP-I and IGFBP-2 mRNA were normalized to ␤-actin to correct for loading variation.
Statistical Analysis
All data were analyzed by the STATISTICA statistical software package for the Macintosh, volume II (StatSoft, Tulsa, OK). A one-way ANOVA was performed to assess main effects, with treatment group (exercise condition ϩ meal condition) as the independent variable. Differences over time were analyzed by two-way ANOVA, with treatment group and exercise time as independent variables. When a significant overall effect was detected, differences among individual means were assessed with Duncan's multiple range post hoc test. The level of significance was set at P Ͻ 0.05 for all statistical tests.
RESULTS
Experiment 1
Plasma insulin after exercise was significantly lower than that for controls at 15 min and 1 h but not different at 4, 8, or 12 h postexercise (Fig. 1) . Plasma IGF-I concentrations in exercised animals were not different from controls at 15 min and 1, 4, and 8 h postexercise and did not change over time (Fig. 1) . Plasma IGF-I in the nonexercised rats was significantly lower than in exercised rats at 12 h.
Representative Western ligand blots for the IGFBP are shown in Fig. 2 . The 29-to 31-kDa IGFBP band (containing IGFBP-1 and -2) in the exercised animals was elevated threefold above controls
Because both IGFBP-1 and IGFBP-2 migrate in the 29-to 31-kDa region on SDS-polyacrylamide gels, Northern analysis was utilized to determine whether one or both IGFBPs were expressed in the liver after exercise (Fig. 3) . At 15 min and 1 h after exercise, hepatic IGFBP-1 mRNA expression in the exercised animals was increased sixfold and threefold, respectively, compared with nonexercised controls (Table 1) . Hepatic IGFBP-2 mRNA expression was low or not detectable in both exercised and nonexercised rats at 15 min and 1 h after exercise. There were no differences in IGFBP-1 or IGFBP-2 mRNA expression between control and exercised animals at 4, 8, and 12 h, but hepatic levels of IGFBP-1 in 12-h rats were higher than in controls at 15 min. Expression of IGFBP-2 mRNA in both exercised and nonexercised rats at 4, 8, and 12 h was higher than in 15-min nonexercised controls.
Experiment 2
Plasma glucose and insulin were elevated at 15 min and 1 h in animals administered a meal immediately after exercise (Table 2 ). There were no differences in plasma glucose or insulin among treatment groups at 3 or 12 h. There were no differences in plasma IGF-I concentrations among treatment groups or across time ( Table 2) .
Plasma IGFBP-1 concentrations (as determined by RIA specific for rat IGFBP-1) in exercised food-deprived animals were 11-and 10-fold higher than in controls at 15 min and 1 h, respectively (Fig. 4) . Additionally, IGFBP-1 concentrations in exercised meal-fed animals were 13-and 16-fold above controls at 15 min and 1 h, respectively, and not different from exercised food-deprived animals at either time point. There were no differences in plasma IGFBP-1 among groups at 3 h postexercise, but the controls tended to be higher than either exercise group at 12 h postexercise (P Ͻ 0.055). Hepatic IGFBP-1 mRNA expression in both exercise groups was increased ϳ11-fold and 2.5-fold above controls at 15 min and 1 h, respectively, and was not different one from the other (Fig. 5 ). There were no differences among groups in IGFBP-1 mRNA expression at 3 h postexercise, but at 12 h the meal-fed rats expressed lower amounts of IGFBP-1 mRNA than either the control or exercise group.
DISCUSSION
This investigation characterizes for the first time the time-course changes in liver IGFBP-1 mRNA expression after a prolonged bout of treadmill exercise, and it provides additional insight into the physiological role of IGFBP-1. After a single bout of exercise, we found dramatic increases in circulating IGFBP-1, reduced levels of insulin, and stable levels of IGF-I and glucose. Stimulation of circulating IGFBP-1 after exercise was short in duration and correlated with increased hepatic mRNA expression. The high levels of expression induced by exercise were unrelated to circulating levels of insulin, IGF-I, or glucose. Feeding a complete meal after exercise did not alter the acute-phase IGFBP-1 response, suggesting that neither amino acid nor glu- cose availability is a key factor in the short-term upregulation of IGFBP-1 gene expression after exercise.
After exercise, sensitivity of skeletal muscle glucose transport activity in response to insulin and IGF-I is increased (11) . Enhanced insulin sensitivity in muscle is counterbalanced by a reduction in plasma insulin at the onset of exercise (3), presumably to prevent exerciseinduced hypoglycemia. Conversely, circulating concentrations of IGF-I show little to no change after exercise (5, 12, 15) . When the potential for IGF-I to bind both the type I receptor and insulin/type I hybrid receptors (8) is considered, an increase in the sensitivity of muscle to IGF-I could lead to increased glucose uptake by muscle. This could potentially result in a disruption of glucose homeostasis, leading to hypoglycemia after exercise.
These observations led to the hypothesis that increases in circulating IGFBP-1 after exercise may prevent IGF-I-induced hypoglycemia by binding free IGF-I in plasma (18). Indeed, infusion of IGFBP-1 into rats prevents the hypoglycemic effect of an infused equimolar solution of IGF-I, and infusion of IGFBP-1 alone causes a small but significant increase in fasting blood glucose levels (18). However, maintenance of euglycemia during cycling exercise did not prevent circulating IGFBP-1 from rising in humans (12) . Similarly in the current study, oral administration of a complete meal immediately after exercise did not prevent an acute rise in circulating IGFBP-1. These data collectively suggest that low plasma glucose concentrations are not required to trigger the IGFBP-1 response to exercise and do not support a direct role for glucose in modulating IGFBP-1 production. However, other factors involved in maintaining glucose homeostasis may play a role. Values are means Ϯ SE; n ϭ 3-4 in each group at each time point. C, nonexercised controls; E, exercised animals not fed after exercise; M, exercised animals fed a nutritionally complete meal immediately after the 2-h experimental run. For each plasma measurement, means in a row not sharing the same letter(s) are different, P Ͻ 0.05. Fig. 4 . Plasma IGFBP-1 in male rats after 2 h of treadmill running. Values are group means Ϯ SE; n ϭ 3-4. C, nonexercised controls; E, exercised animals; M, exercised and fed a nutritionally complete meal immediately after exercise. Group means not sharing the same letter are significantly different, P Ͻ 0.05. Insulin is proposed to be a primary regulator of circulating IGFBP-1 under most physiological conditions (17) . However, this does not appear to be the case after prolonged exercise in humans, for plasma levels of IGFBP-1 are significantly elevated immediately after a marathon run despite similar pre-and postmarathon plasma insulin values (15) . Additionally, maintenance of plasma insulin levels by consumption of a purely carbohydrate drink during exercise did not prevent IGFBP-1 levels from rising (12) . In the current study, plasma insulin did not correlate with plasma IGFBP-1 or hepatic IGFBP-1 mRNA abundance, further demonstrating that plasma concentrations of insulin do not predict circulating levels of IGFBP-1 after exercise.
In previous studies, a purely carbohydrate beverage was the only dietary treatment utilized to examine the effect of feeding on plasma IGFBP-1 during and after exercise (12, 15) . To date, no studies have investigated the impact of amino acids on IGFBP-1 production after exercise. Studies in human HepG2 cells and isolated rat hepatocytes demonstrate that amino acid limitation strongly induces IGFBP-1 expression without affecting IGF-I expression (14) . Moreover, treatment of hepatic cells with amino acids at concentrations that mimic those observed in the blood of rats fed a lowprotein diet also induces IGFBP-1 expression (14) . With this in mind, we hypothesized that the provision of a nutritionally complete meal containing an exogenous source of amino acids would prevent increased hepatic expression of IGFBP-1 after exercise. However, consumption of the protein-containing meal immediately after exercise did not blunt circulating IGFBP-1 concentrations or hepatic mRNA expression of IGFBP-1 compared with exercised food-deprived animals. These data indicate that supplemental protein has no effect on IGFBP-1 regulation immediately after exercise.
An alternate role for increased production of IGFBP-1 is to modulate the anabolic, rather than the metabolic, effects of IGF-I. Studies in human skeletal muscle cells demonstrate the addition of IGFBP-1 to culture media to inhibit IGF-I-stimulated protein synthesis, suggesting that increased production of IGFBP-1 may prevent free IGF-I from interacting with the type I receptor in muscle after exercise (9) . Indeed, prolonged exercise results in a significant reduction in the rate of protein synthesis in mixed skeletal muscle of rats (10). However, feeding a protein-containing meal immediately after exercise results in complete recovery of muscle protein synthesis by 1 h postexercise (10), whereas feeding this same protein-containing meal did not abate IGFBP-1 levels in the current study. Therefore, the two processes appear to be unrelated.
Although there were few or no differences in IG-FBP-2 gene expression between control and exercised rats throughout the time course, mRNA expression of IGFBP-2 in both treatment groups increased steadily over time. Additionally, IGFBP-1 gene expression in control and exercised rats was elevated at 12 h compared with rats receiving a postexercise meal. These results are likely due to prolonged food deprivation, for rats killed at 12 h postexercise were food deprived for ϳ18 h. Liver IGFBP-2 gene expression is sharply elevated by fasting and decreased by refeeding (6, 22) . The hepatic mRNA abundance of IGFBP-1 is also increased in nutritionally restricted animals (22) . These effects are caused primarily by an increase in transcription of the IGFBP-1 and IGFBP-2 genes (26). Therefore, nutritional status appears to regulate IGFBP-1 and IG-FBP-2 transcription independently of exercise.
The hypothesis that IGFBP-1 is involved in glucoregulation cannot be discounted by the current findings, for many factors are involved in maintaining glucose homeostasis. One likely candidate that could maintain glucose homeostasis in part via increasing IGFBP-1 production is the steroid hormone corticosterone. When we consider that the IGFBP-1 promoter contains a glucocorticoid response element (17) and that the glucocorticoids are intimately involved in glucose counterregulation, this is an attractive possibility. Prolonged exercise increases circulating concentrations of corticosterone in rats (10) , and this hormone increases in relation to the degree of metabolic stress. The stress of exercise may be an important factor in the IGFBP-1 response. In support of this hypothesis, 30 min of cycle exercise did not alter plasma concentrations of IGFBP-1 (23), whereas exercise bouts of longer duration resulted in significant elevations in plasma IGFBP-1 (2, 15, 21, 27) . Further investigation is needed to determine the factor(s) involved in regulating IGFBP-1 production after exercise.
In summary, this report describes the time course for changes in plasma concentrations and hepatic gene expression of IGFBP-1 after prolonged exercise. Plasma concentrations and hepatic mRNA expression of IGFBP-1 rise markedly immediately after exercise but return to control values within a few hours. Factors other than insulin, glucose, and amino acid availability directly regulate IGFBP-1 immediately after exercise, for circulating concentrations of insulin and glucose do not predict plasma IGFBP-1 concentrations or hepatic IGFBP-1 mRNA expression after exercise. Furthermore, ingestion of a nutritionally complete meal containing an exogenous source of amino acids does not influence the plasma or hepatic IGFBP-1 profile immediately after exercise. Investigation into other factors underlying the IGFBP-1 response to exercise is needed to elucidate the physiological role of IGFBP-1 during exercise recovery.
